Éric Delaporte
About
In The Last Decade
Éric Delaporte
516 papers receiving 14.4k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Infectious Diseases 7.8k
- Virology 7.0k
- Epidemiology 4.6k
- Immunology 2.2k
- Molecular Biology 1.0k
Countries citing papers authored by Éric Delaporte
This map shows the geographic impact of Éric Delaporte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Éric Delaporte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Éric Delaporte more than expected).
Fields of papers citing papers by Éric Delaporte
This network shows the impact of papers produced by Éric Delaporte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Éric Delaporte. The network helps show where Éric Delaporte may publish in the future.
Co-authorship network of co-authors of Éric Delaporte
This figure shows the co-authorship network connecting the top 25 collaborators of Éric Delaporte. A scholar is included among the top collaborators of Éric Delaporte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Éric Delaporte. Éric Delaporte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 27 | |
| 5 | 17 | |
| 6 | 14 | |
| 7 | 1 | |
| 8 | Efficacy of dual therapy with protease inhibitors plus lamivudine as maintenance treatment in HIV-positive patients on second line in Africa : the ANRS 12286/MOBIDIP trial 96-week results | 1 |
| 9 | A case series of 11 uveitis in patients who recovered from Ebola in Guinea | 2 |
| 10 | Virological outcome and frequency of drug resistance mutations in HIV-infected patients receiving first-line ARV regimen and monitored with the clinical approach in the Cameroon National ART Program | 1 |
| 11 | 6 | |
| 12 | 164 | |
| 13 | 9 | |
| 14 | Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1 breakdown → | 555 |
| 15 | Complications cutanées de la radiothérapie (hors tumeurs malignes) | 9 |
| 16 | Diversité génétique de l'infection à VIH dans le monde et ses conséquences | 0 |
| 17 | 7 | |
| 18 | 18 | |
| 19 | 42 | |
| 20 | Blood transfusion as a major risk factor for HTLV-I infection among hospitalized children in Gabon (Equatorial Africa). | 14 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.